Community post

Microbiome Times analysed its Microbiome Drug Database™, a repository of biotechs developing microbiome drugs, for phage-related drugs. They found that almost 70% of the total of 100 company-sponsored, phage-based drug development programs in their database focus on the treatment of infections.